Retapamulin
| Use attributes for filter ! | |
| Molar mass | 517. 77 g/mol |
|---|---|
| ChEMBL Id | 566434 |
| License data | EMA |
| US | |
| FDA | |
| ATC code | D06AX13 (WHO) |
| ChemSpider ID | 25064484 |
| Music groups | Mupirocin |
| Fusidic acid | |
| Dicloxacillin | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2964325 |
About Retapamulin
Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It is the first drug in the new class of pleuromutilin antibiotics to be approved for human use. It is marketed as an ointment under the brand names Altabax and Altargo.